Avacta Acquires Coris Bioconcept
With the acquisition, Avacta gains Coris’ product portfolio including diagnostic tests for respiratory, gastro-enteric, and blood-borne pathogens and for the detection of antibiotic resistance markers.
Read More
Search Results for: covid-19
FDA Issues Class I Recall for COVID-19 At-Home Tests
This Class I recall is for certain COVID-19 at-home test kits containing liquid solution that may be contaminated with bacteria.
Read More
Program Supports Need to Expand Diagnostic Testing Access
The CDC’s OneLab TEST is designed for anyone who performs or coordinates diagnostic testing at non-laboratory sites.
Read More
Cancer Screening Delays Due to COVID-19 Fuel Rise in Diagnoses
Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases.
Read More
Affordable At-Home Molecular Test for COVID-19, Flu-A, Flu-B & RSV Moving Closer
The award through the NIH’s RADx Tech program, will support Domus Diagnostics’ at-home molecular test for clinical trial readiness.
Read More